Veri Medtech operates a healthcare technology platform focused on medical marijuana certifications. Through its subsidiary Veriheal, the company connects patients with licensed physicians and manages the paperwork for state medical cannabis applications. The platform provides an end-to-end service where patients book appointments, undergo telemedicine or in-person evaluations, and receive certifications. This core business accounts for nearly all of the company's revenue through initial evaluation fees and annual renewals. Veri Medtech acquires customers primarily through digital marketing and its property, MarijuanaDoctors.com. Operations are sensitive to state-level regulations, as mandates for in-person visits over telehealth impact patient volume. Beyond certifications, Veri Medtech is developing DosePop, a direct-to-consumer telemedicine platform. DosePop targets younger consumers with subscription-based access to prescription treatments for weight loss, dermatology, ADHD, and sexual health. The company's strategy involves expanding certification services into new domestic and international markets, monetizing patient data, and acquiring complementary healthcare platforms. Veri Medtech also established Sky Clinics to serve as a clinical infrastructure provider. Primary costs include physician fees, payment processing, and marketing.
Read full business overview →Mid to long-term bullish thesis
View →Mid to long-term bearish thesis
View →Mid to long-term bull-bear debate
View → NEWSummary and scoring of the bull-bear debate
View →Find ideas with similar bull or bear theses
View →Investor-relevant company attributes
View →Key risks to the business
View →Comparisons of annual risk disclosures
View →